Researchers enrolled 17,604 adults who: were 45 years or older had overweight or obesity (BMI 27) already had heart disease (such as a prior heart attack, stroke, or peripheral artery disease) did not have diabetes Participants were randomly assigned to receive either: semaglutide 2.4 mg weekly, or a placebo (an injection with no active medication) They were followed for about 40 months (over 3 years)
Similarly, JP Morgan 6 forecasts that the use of GLP-1RA drugs for both weight loss and diabetes indications in the U.S
Common side effects from taking other forms of B12 are typically attributed to the added preservative these include hot flashes, dizziness, and nausea
It may even be its primary job, Liu says
Exposure to Radiation: Radiation from medical imaging (like X-rays and CT scans) or environmental sources (such as UV rays from the sun) generates free radicals
The GRADE assessment rated 36 outcomes (26%) as High, 34 (24%) as Moderate, 31 (22%) as Low, and 40 (28%) as Very Low